pneumonia
still
number
one
killer
young
children
global
account
mortal
children
year
age
estim
million
new
case
pneumonia
occur
global
year
develop
countri
manag
prevent
effort
pneumonia
tradit
focus
bacteri
pathogen
recent
howev
viral
pathogen
gain
attent
result
improv
diagnost
method
polymeras
chain
reaction
outbreak
sever
diseas
caus
emerg
pathogen
discoveri
new
respiratori
virus
well
decreas
bacteri
pneumonia
consequ
introduct
highli
effect
conjug
vaccin
although
epidemiolog
etiolog
clinic
character
viral
infect
studi
extens
develop
world
littl
data
avail
lowand
middleincom
countri
paper
review
epidemiolog
etiolog
clinic
radiolog
featur
viral
pneumonia
develop
countri
pneumonia
still
number
one
killer
young
children
global
account
mortal
children
year
age
estim
million
new
case
pneumonia
occur
global
year
develop
countri
manag
prevent
effort
pneumonia
tradit
focus
bacteri
pathogen
recent
howev
viral
pathogen
gain
attent
result
improv
diagnost
method
polymeras
chain
reaction
outbreak
sever
diseas
caus
emerg
pathogen
discoveri
new
respiratori
virus
well
decreas
bacteri
pneumonia
consequ
introduct
highli
effect
conjug
vaccin
although
epidemiolog
etiolog
clinic
character
viral
infect
studi
extens
develop
world
littl
data
avail
lowand
middleincom
countri
paper
review
epidemiolog
etiolog
clinic
radiolog
featur
viral
pneumonia
develop
countri
despit
signific
reduct
child
mortal
last
decad
pneumonia
remain
lead
caus
childhood
mortal
worldwid
account
death
children
year
age
estim
million
new
case
pneumonia
occur
global
year
addit
estim
million
ci
million
episod
sever
sever
acut
lower
respiratori
infect
alri
young
children
result
hospit
admiss
develop
countri
manag
prevent
effort
pneumonia
tradit
focus
bacteri
pathogen
known
caus
sever
pneumonia
case
among
pathogen
two
bacteria
stand
major
caus
diseas
streptococcu
pneumonia
haemophilu
influenza
type
b
hib
scarciti
routin
microbiolog
facil
resourceconstrain
set
low
sensit
current
bacteri
identif
method
hinder
adequ
surveil
may
turn
contribut
underestim
real
burden
pathogen
relev
impact
bacteria
caus
pneumonia
clearli
establish
prior
introduct
pneumococc
hib
conjug
vaccin
recent
howev
attent
shift
toward
nonbacteri
caus
pneumonia
name
viral
respiratori
infect
respiratori
syncyti
viru
rsv
wide
studi
develop
develop
countri
estim
caus
alri
death
annual
addit
rsv
virus
emerg
major
caus
pneumonia
potenti
lifethreaten
respiratori
syndrom
viral
pathogen
gain
recent
interest
result
improv
diagnost
method
pcr
outbreak
sever
diseas
caus
emerg
pathogen
avian
influenza
pandem
influenza
discoveri
new
respiratori
virus
human
metapneumoviru
hmpv
human
coronaviru
hcov
human
bocaviru
hbov
human
rhinoviru
hrv
speci
c
furthermor
introduct
highli
effect
conjug
vaccin
global
led
decreas
bacteri
pneumonia
consequ
rise
promin
virus
although
epidemiolog
etiolog
clinic
character
infect
children
current
studi
extens
develop
world
littl
microbiolog
confirm
data
avail
lowand
even
middleincom
countri
paper
review
epidemiolog
etiolog
clinic
radiolog
featur
viral
pneumonia
develop
countri
data
retriev
countri
highlight
figur
major
challeng
review
publish
literatur
acut
respiratori
infect
ari
children
lack
gold
standard
univers
accept
case
definit
pneumonia
lack
gold
standard
definit
hamper
homogen
approach
pneumonia
research
decad
therefor
decid
use
nonrestrict
approach
systemat
literatur
search
incorpor
wide
varieti
util
case
definit
pneumonia
tabl
defin
develop
countri
use
world
bank
intern
monetari
found
imf
classif
includ
studi
perform
countri
newli
industri
categori
includ
brazil
peopl
republ
china
india
mexico
philippin
south
africa
thailand
turkey
imf
undertook
systemat
literatur
review
use
variou
search
term
medlin
embas
appendix
well
handsearch
onlin
journal
includ
differ
age
rang
inclus
criteria
ari
alri
sever
alri
sever
alri
influenzalik
ill
radiolog
confirm
pneumonia
whodefin
pneumonia
differ
detect
techniqu
util
viral
detect
pcr
immunofluoresc
antibodi
test
enzymelink
immunosorb
assay
shellvial
viral
cultur
differ
number
viru
studi
singl
viru
detect
studi
multiplevir
detect
studi
final
differ
sampl
studi
nasopharyng
aspir
npa
nasal
pharyng
swab
bronchial
aspir
lung
punctur
address
public
health
issu
thorough
knowledg
epidemiolog
viral
pneumonia
mandatori
epidemiolog
ari
develop
world
adequ
character
case
develop
countri
scarciti
reliabl
surveil
data
resourceconstrain
set
incid
calcul
either
roughli
estim
base
limit
number
geograph
limit
area
demograph
surveil
system
dss
set
context
research
effort
furthermor
set
data
adult
elderli
patient
review
lanaspa
annamalay
bassat
extrem
scarc
unexist
develop
countri
incid
ari
highest
among
children
younger
year
age
decreas
greatli
year
age
increas
among
adult
older
year
age
avail
data
develop
world
suggest
similar
agedistribut
tendenc
although
rise
pneumonia
incid
observ
among
young
adult
set
high
hiv
preval
total
studi
south
america
asia
africa
present
incid
data
alri
virusspecif
associ
alri
present
incid
adult
incid
rate
summar
pediatr
popul
african
set
incid
alri
rang
case
per
childrenyearatrisk
cyar
alri
case
per
cyar
sever
alri
asian
set
incid
alri
sever
alri
rang
case
per
cyar
respect
south
america
incid
alri
case
sever
case
avail
rang
case
per
cyar
discrep
differ
set
may
part
explain
differ
age
group
year
studi
definit
hamper
accur
epidemiolog
comparison
among
region
children
year
age
vong
et
al
alri
symptom
onset
day
fever
histori
fever
last
day
cough
one
follow
dyspnea
chest
pain
crackl
auscult
feikin
et
al
alri
cough
difficulti
breath
chest
pain
fever
oxygen
satur
hospit
studi
includ
least
subject
publish
last
year
consid
case
definit
agespecif
tachypnea
cough
andor
difficulti
breath
alri
acut
lower
respiratori
infect
cap
communityacquir
pneumonia
lrti
lower
respiratori
tract
infect
review
wwwexpertreviewscom
studi
recruit
consecut
month
henc
season
could
alway
infer
sinc
sever
report
sitespecif
viru
season
especi
rsv
influenza
viru
hmpv
tabl
rsv
hmpv
particular
seem
frequent
detect
raini
season
america
africa
asia
except
nigeria
south
africa
rsv
show
higher
incid
dri
season
interestingli
lung
sampl
fatal
pneumonia
episod
children
age
mexico
posit
rsv
hrv
second
frequent
report
viru
although
studi
rank
first
especi
children
age
alri
sever
alri
hrv
detect
respect
studi
type
hrv
hrva
frequent
identifi
speci
sever
nonsever
alri
hrvb
rare
detect
hrv
speci
distribut
consist
among
african
asian
american
set
although
recent
report
nondevelop
set
name
australia
highlight
pathogen
role
newli
describ
hrvc
potenti
impact
caus
pediatr
sever
respiratori
diseas
hospit
admiss
adv
influenza
piv
record
alri
case
respect
howev
adv
consist
frequent
identifi
rsv
sampl
mozambiqu
three
larg
studi
two
sever
alri
case
children
age
trend
confirm
studi
except
malawian
studi
lung
punctur
sampl
radiolog
confirm
pneumonia
review
wwwexpertreviewscom
posit
adv
popul
high
burden
hiv
import
condit
need
investig
newli
describ
respiratori
virus
hmpv
record
alri
case
hcov
hbov
final
two
studi
report
polyomaviru
infect
alri
children
year
age
philippin
children
younger
year
age
thailand
respect
consid
comprehens
studi
detect
pcr
least
virus
studi
popul
larger
patient
minimum
period
gener
preval
viral
infect
rang
hrv
rsv
influenza
adv
hmpv
commonli
detect
pathogen
viral
etiolog
infer
proper
casecontrol
studi
includ
healthi
andor
asymptomat
children
conduct
compar
preval
viral
pathogen
group
calcul
attribut
fraction
studi
design
current
util
pneumonia
etiolog
research
child
health
perch
studi
could
help
clarifi
role
respiratori
virus
hrv
viral
pneumonia
eleven
studi
conduct
countri
includ
gambia
kenya
nepal
thailand
vietnam
includ
control
group
compar
viru
preval
patient
either
pneumonia
sever
pneumonia
radiolog
confirm
pneumonia
viru
indisput
associ
pneumonia
rsv
significantli
preval
three
pneumonia
case
definit
differ
age
group
influenza
relat
hospit
pneumonia
children
age
children
younger
year
age
sever
pneumonia
two
studi
conduct
kenya
patient
sever
pneumonia
age
respect
demonstr
variabl
result
signific
associ
influenza
sever
pneumonia
larger
studi
hrv
hmpv
piv
mostli
unrel
pneumonia
differ
casecontrol
studi
although
signific
associ
found
hrv
pneumonia
age
group
odd
ratio
ci
except
one
studi
infant
thailand
studi
hrv
genotyp
type
signific
attain
speci
c
b
interestingli
hmpv
relat
pneumonia
children
older
year
age
younger
younger
associ
increas
risk
pneumonia
ci
children
age
adv
hcov
hbov
relat
pneumonia
casecontrol
studi
includ
detect
pneumonia
major
caus
death
hospit
admiss
hivinfect
children
subsaharan
africa
pediatr
hiv
epidem
essenti
circumscrib
studi
describ
singular
hivassoci
pneumonia
cytomegaloviru
cmv
viral
pathogen
respons
mononucleosislik
influenzalik
ill
immunocompet
children
lead
caus
pneumonia
hivinfect
children
studi
children
sever
alri
south
africa
cmv
identifi
hivinfect
children
uninfect
children
sever
malnourish
furthermor
cmv
common
pneumocysti
jirovecii
pneumonia
viralassoci
pneumonia
anoth
studi
hmpv
indentifi
infect
hivinfect
hivuninfect
children
respiratori
virus
also
commonli
identifi
among
hivinfect
patient
sever
alri
although
less
frequent
among
hivuninfect
children
one
like
explan
role
pathogen
sever
pneumonia
immunocompromis
patient
larg
studi
children
younger
year
age
admit
sever
pneumonia
virus
bacteria
identifi
hivinfect
patient
compar
hivuninfect
case
respect
p
jirovecii
detect
among
hivinfect
children
studi
cmv
hmpv
test
possibl
result
underestim
relev
viral
pathogen
caus
alri
hivinfect
patient
children
polymicrobi
infect
common
hivuninfect
patient
also
appear
associ
wors
prognosi
clinic
featur
similar
hmpvassoci
alri
piv
influenzaassoci
alri
wheez
less
frequent
alveolar
consolid
frequent
hivinfect
hivuninfect
children
fatal
outcom
record
hivinfect
hivuninfect
children
viral
pneumonia
cmv
caus
wors
prognosi
viru
tabl
lymphoid
interstiti
pneumon
lip
lymphoprolif
respons
hiv
andor
epsteinbarr
viru
common
hivinfect
children
older
year
age
without
proper
antiretrovir
treatment
although
lip
chronic
lung
diseas
may
present
intermitt
episod
alri
fever
tachypnea
mostli
due
bacteri
superinfect
digit
cubbl
gener
lymphadenopathi
hepatomegali
common
children
lip
characterist
radiolog
find
includ
persist
diffus
bilater
reticulonodular
pattern
identifi
studi
includ
adult
report
detect
rate
adult
children
tabl
viral
detect
rate
adult
alri
except
studi
lao
patient
hospit
alri
sampl
posit
least
one
viru
valu
must
consid
caution
small
size
studi
hrv
frequent
report
viru
detect
studi
test
influenza
detect
alri
adult
case
usual
second
commonli
identifi
viru
hrv
except
studi
conduct
vietnam
pandem
influenza
frequent
detect
viru
rsv
document
case
hmpv
adv
hbov
adult
alri
case
two
studi
report
data
stratifi
accord
age
group
influenzarel
alri
hrvrelat
alri
show
decreas
viral
detect
age
sinc
advent
multiplexpcr
allow
simultan
detect
respiratori
virus
multipl
virus
specimen
increasingli
identifi
pneumonia
etiolog
studi
multipl
viral
infect
report
adult
children
lowest
highest
coinfect
rate
children
report
studi
use
multiplex
pcr
similar
age
group
year
vs
year
age
dispar
may
due
epidemiolog
differ
variou
set
frequent
detect
combin
usual
includ
preval
virus
identifi
studi
rsvhmpv
rsvhrv
rsvinfluenza
hrvadv
hbov
frequent
detect
associ
respiratori
virus
follow
polyomaviru
adv
hcov
piv
hrv
hmpv
rsv
clinic
relev
associ
remain
unclear
studi
find
differ
sever
due
viral
codetect
compar
singl
viru
identif
howev
two
studi
mozambiqu
report
multipl
viral
infect
case
sever
pneumonia
found
signific
associ
nasal
flare
ci
lower
chest
indraw
ci
fatal
outcom
ci
studi
report
increas
risk
develop
alri
children
rsvhrv
rsvhmpv
coinfect
rsvinfluenza
coinfect
longer
hospit
length
oxygen
requir
rsvhrv
coinfect
toddler
larg
studi
children
adult
radiolog
confirm
pneumonia
thailand
singl
hbov
infect
associ
alri
hospit
howev
hbov
codetect
rsv
hrv
piv
associ
wheez
sign
respiratori
distress
frequent
rsv
hrv
piv
singl
infect
whopropos
case
definit
pneumonia
part
integr
manag
childhood
ill
imci
strategi
save
live
odd
ratio
year
review
wwwexpertreviewscom
million
children
develop
world
highli
sensit
albeit
poorli
specif
case
definit
aim
maxim
detect
potenti
lifethreaten
alri
episod
prompt
rapid
initi
lifesav
antibiot
therapi
respiratori
nonrespiratori
ill
might
fulfil
allembrac
definit
patient
clinic
present
may
benefit
antibiot
therapi
particularli
caus
alri
exclus
viral
infect
furthermor
malariaendem
countri
sever
malaria
might
also
present
respiratori
distress
tachypnea
reason
given
scarciti
antibiot
particularli
widespectrum
one
thirdgener
cephalosporin
mani
develop
set
togeth
emerg
antimicrobi
resist
commonli
avail
import
identifi
featur
could
reliabl
distinguish
viral
bacteri
pneumonia
could
clearli
relev
manag
public
health
implic
clinician
polici
maker
develop
countri
develop
countri
diagnosi
pneumonia
reli
combin
clinic
sign
symptom
radiolog
result
laboratori
test
develop
countri
hospit
outsid
urban
area
rare
xray
facil
access
laboratori
test
procalcitonin
pct
creactiv
protein
crp
diagnost
biomark
usual
limit
clinic
research
thu
context
diagnosi
often
pure
clinic
although
standard
xraybas
case
definit
propos
use
epidemiolog
studi
clinic
trial
studi
sweden
pediatr
case
confirm
pneumonia
underw
extens
microbiolog
test
conclud
xray
featur
relat
etiolog
author
describ
hyperinfl
interstiti
infiltr
frequent
viral
pneumonia
alveolar
infiltr
bacteri
pneumonia
descript
specif
howev
found
relat
age
conclud
age
might
confound
xray
interpret
studi
carri
china
describ
xray
featur
pediatr
case
less
year
age
viral
pneumonia
report
patient
patchi
area
consolid
interstiti
infiltr
lobar
consolid
bilater
affect
lower
lobe
frequent
author
found
advrel
pneumonia
associ
interstiti
infiltr
season
influenza
diffus
area
air
space
consolid
found
specif
featur
relat
influenza
b
piv
pneumonia
howev
respiratori
virus
commonli
caus
viral
pneumonia
test
anoth
studi
thailand
children
age
year
describ
signific
relationship
rsvassoci
pneumonia
interstiti
infiltr
interestingli
pneumonia
case
show
lobar
consolid
posit
rsv
similar
studi
brazil
rsvposit
patient
rsvneg
patient
ident
interstiti
infiltr
relat
could
establish
clinic
featur
etiolog
studi
carri
larg
varieti
set
report
similar
result
frequent
pattern
viral
pneumonia
rsv
studi
viru
includ
interstiti
peribronchi
infiltr
alveolar
lobar
consolid
rare
find
viral
pneumonia
mix
pattern
frequent
viral
bacterialconfirm
pneumonia
episod
thu
fair
conclud
etiolog
diagnosi
specif
respiratori
viru
viru
vs
bacteria
made
basi
xray
featur
alon
pediatr
pneumonia
adult
radiolog
find
viral
pneumonia
variabl
highli
overlap
moreov
corrobor
lobar
consolid
andor
pleural
effus
rare
adult
viral
pneumonia
seri
kenyan
adult
patient
viral
pneumonia
lobar
multilobar
consolid
pattern
seen
patient
patchi
consolid
seen
one
although
studi
small
noteworthi
lung
aspir
perform
rule
bacteri
diseas
howev
patient
hivinfect
radiolog
pattern
could
alter
condit
clinician
develop
countri
reli
clinic
evalu
initi
orient
probabl
etiolog
patient
despit
poor
specif
clinic
symptom
purpos
studi
carri
turku
univers
hospit
finland
children
laboratoryconfirm
viral
respiratori
infect
compar
clinic
featur
eight
differ
respiratori
virus
hrv
rsv
adv
influenza
viru
influenza
viru
b
found
overlap
symptomatolog
frequent
overlap
clinic
present
also
common
develop
countri
importantli
viral
pneumonia
sign
symptom
seem
overlap
bacteri
pneumonia
studi
children
less
year
age
alri
thailand
author
unabl
identifi
clinic
sign
differenti
viral
bacteri
etiolog
also
observ
studi
children
year
age
sudan
studi
compar
virusposit
pneumonia
versu
virusneg
pneumonia
fail
identifi
signific
differ
low
sensit
bacteri
diagnosi
mostli
base
blood
cultur
may
underestim
viralbacteri
coinfect
virusposit
group
lead
conflict
result
howev
wheez
shown
signific
associ
viral
pneumonia
studi
present
children
adult
rsvrelat
alri
usual
present
crackl
wheez
nasal
flare
lower
chest
indraw
rhinorrhea
nasal
obstruct
frequent
virus
unfortun
none
clinic
featur
clearli
specif
rsv
infect
wheez
also
associ
hrv
particularli
hrvc
hmpv
hbov
reactiv
airway
diseas
sequel
previou
viral
infect
lead
repeat
wheez
episod
readmiss
describ
rsv
infect
also
influenzarel
alri
studi
rsv
character
sever
present
term
oxygen
requir
hypoxemia
sign
respiratori
distress
studi
found
hrv
infect
sever
children
adult
final
studi
conclud
sever
associ
viru
case
fatal
rate
report
rsvassoci
alri
children
differ
set
sever
influenzaassoci
alri
year
rural
kenya
influenzaassoci
alri
children
adult
seri
kenya
hmpvassoci
alri
indonesia
among
pathogen
respiratori
virus
addit
avian
influenza
may
associ
case
fatal
rate
high
earli
antivir
treatment
without
treatment
develop
countri
serum
biomark
pct
crp
use
distinguish
viral
bacteri
infect
especi
children
serum
pct
crp
level
increas
bacteri
infect
cutoff
ngml
mgl
respect
commonli
studi
biomark
includ
ifna
tnfg
lipopolysaccharidebind
protein
heparinbind
protein
shown
higher
sensit
specif
predict
valu
pct
crp
purpos
metaanalysi
compar
pct
crp
differenti
bacteri
viral
infect
pct
sensit
specif
higher
fals
discoveri
rate
q
valu
crp
develop
countri
afford
rapid
simpl
diagnost
tool
purpos
crucial
assur
adequ
manag
antibiot
especi
view
low
specif
clinic
featur
pct
crp
prove
use
marker
bacteri
diagnosi
african
set
howev
serum
level
pct
crp
increas
patient
malaria
infect
henc
may
compromis
util
malariaendem
set
research
area
undertaken
aim
develop
rapid
diagnost
test
ideal
pointofcar
test
capabl
identifi
underli
etiolog
infect
sever
ill
patient
admiss
antivir
rare
use
develop
countri
except
avian
influenza
case
oseltaminvir
amantadin
rimantadin
rivabirin
test
good
result
initi
promptli
lack
rapid
etiolog
diagnosi
render
option
unsuit
clinician
resourceconstrain
area
follow
recommend
antibiot
initi
patient
fulfil
clinic
pneumonia
case
definit
passiv
immun
use
specif
monoclon
antibodi
use
develop
countri
manag
rsv
infect
particularli
among
highli
select
highrisk
popul
extrem
preterm
congenit
heart
defect
patient
epidem
prohibit
price
howev
make
unrealist
option
develop
countri
thu
prevent
control
viral
respiratori
diseas
primarili
focus
vaccin
unfortun
regist
vaccin
respiratori
virus
suitabl
use
children
younger
month
age
popul
highest
risk
older
children
adult
avail
vaccin
market
season
influenza
although
vaccin
includ
expand
program
immun
children
immun
pregnant
women
reli
protect
mothertochild
transfer
antibodi
immun
postpartum
mother
household
contact
studi
strategi
reduc
influenza
viru
burden
young
children
promis
result
polyval
vaccin
rsv
evalu
phase
trial
good
safeti
profil
vaccin
hmpv
hrv
still
preclin
stage
widespread
avail
expect
shortterm
develop
countri
similar
occur
develop
set
respiratori
virus
import
caus
pneumonia
particularli
among
young
children
howev
real
burden
presum
heavili
underestim
pathogen
role
specif
virus
viral
subtyp
detect
upper
respiratori
tract
patient
pneumonia
still
requir
clarif
thu
welldesign
casecontrol
studi
provid
robust
data
pathogenspecif
attribut
diseas
fraction
requir
addit
new
diagnost
method
biomark
clearli
differenti
pathogen
colon
pathogen
caus
diseas
homogen
clinic
radiolog
definit
inclus
criteria
laboratori
test
also
necessari
allow
comparison
among
studi
clearli
detect
prioriti
public
health
polici
maker
real
underexpos
burden
viral
pneumonia
resourceconstrain
set
emerg
true
magnitud
signific
review
wwwexpertreviewscom
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
includ
employ
consult
honoraria
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
write
assist
util
product
manuscript
despit
great
reduct
child
mortal
last
decad
pneumonia
remain
major
killer
young
children
global
account
mortal
recent
year
attent
shift
toward
nonbacteri
caus
pneumonia
specif
viralattribut
respiratori
infect
data
viral
pneumonia
develop
countri
scarc
develop
countri
highest
incid
acut
respiratori
infect
ari
evidenc
among
children
younger
year
age
fall
dramat
year
age
increas
among
adult
older
year
age
avail
data
develop
world
suggest
similar
agedistribut
tendenc
consid
comprehens
studi
detect
pcr
least
virus
studi
popul
larger
patient
minimum
period
preval
viral
infect
pediatr
pneumonia
case
rang
human
rhinoviru
respiratori
syncyti
viru
influenza
viru
adenoviru
human
metapneumoviru
commonli
detect
pathogen
adult
pneumonia
case
human
rhinoviru
influenza
frequent
detect
virus
causal
infer
posit
viral
isol
respiratori
sampl
especi
upper
respiratori
tract
sampl
given
lack
control
studi
overlap
clinic
radiolog
present
common
viral
pneumonia
case
caus
differ
respiratori
viru
importantli
viral
pneumonia
sign
symptom
seem
overlap
bacteri
pneumonia
serum
biomark
use
develop
countri
distinguish
viral
bacteri
infect
procalcitonin
creactiv
protein
increas
patient
malaria
infect
compromis
util
malariaendem
set
regist
vaccin
respiratori
virus
suitabl
use
children
younger
month
age
popul
highest
risk
studi
includ
comparison
differ
diagnosi
method
odd
ratio
sever
sever
pneumonia
viru
